Effects of ibopamine on fluid retention were assessed in eight cirrhotic patients with ascites, after a period on a controlled diet and without diuretics. Ibopamine alone (100 mg BID) was administered for one week, followed by diuretics (muzolimine and/or canrenone) for one week. No increase in diuresis and no reduction of fluid retention were observed in the first week during ibopamine treatment. A significant increase in diuresis and a decrease in ascites and body weight were obtained only when diuretics were administered concomitantly.

Failure of ibopamine in the treatment of cirrhotic ascites

CATALANO, Daniela;
1987-01-01

Abstract

Effects of ibopamine on fluid retention were assessed in eight cirrhotic patients with ascites, after a period on a controlled diet and without diuretics. Ibopamine alone (100 mg BID) was administered for one week, followed by diuretics (muzolimine and/or canrenone) for one week. No increase in diuresis and no reduction of fluid retention were observed in the first week during ibopamine treatment. A significant increase in diuresis and a decrease in ascites and body weight were obtained only when diuretics were administered concomitantly.
1987
dopamine receptor stimulating agent,; ibopamine
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11769/41017
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 2
social impact